Prosecution Insights
Last updated: April 19, 2026

Heidelberg Biotech GmbH

1 pending office actions

Portfolio Summary

1
Total Pending OAs
0
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18494682 MEANS AND METHODS FOR THE TREATMENT OF ANGIOGENESIS-, FIBROSIS- AND CANCER-RELATED DISEASES WITH PROTEIN OLIGOMERS COMPRISING NC-1-FC MIKNIS, ZACHARY J 1658 Non-Final OA Oct 25, 2023

Managing Heidelberg Biotech GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month